Genes & Cancer

03/27/2026

Impact Journals (publisher of Genes & Cancer) is a proud at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2026, taking place April 17–22 at the San Diego Convention Center.

Be sure to stop by Booth 3641 to meet members of the team, explore the latest publications, and discuss opportunities for and .

https://www.impactjournals.com/journals/blog/news/impact-journals-to-participate-at-aacr-annual-meeting-2026-in-san-diego/

03/27/2026

Learn more about the Genes & Cancer Editorial Board:

🔗 https://www.genesandcancer.com/editorial-board/

03/27/2026

: "Oncogenes in high grade serous adenocarcinoma of the o***y"

DOI ⬇️
https://doi.org/10.18632/genesandcancer.206

https://doi.org/10.18632/genesandcancer.206 Pacharla Manasa, Chirukandath Sidhanth, Syama Krishnapriya, Sekar Vasudevan, Trivadi S. Ganesan

03/26/2026

🧬 The journal covers all aspects of the structure & function of oncogenes, growth suppressor and apoptotic genes, their role in signal transduction and mechanisms by which their expression and function are altered during tumor development.

🔗 https://www.genesandcancer.com/

Genes & Cancer is an open-access, peer-reviewed journal that publishes research focused on cancer, genomics, bioinformatics, and modern genetics.

03/26/2026

: "Multi-kinase targeted therapy as a promising treatment strategy for ovarian tumors expressing sfRon receptor"

DOI ⬇️
https://doi.org/10.18632/genesandcancer.205

https://doi.org/10.18632/genesandcancer.205 Luyao Wang, Lin Wang, Magdalena Cybula, Ana Luiza Drumond-Bock, Katherine M. Moxley, Magdalena Bieniasz

03/25/2026

For :
We aim to amplify your work's visibility. Our in-house digital team crafts & circulates original inspired by published in Genes & Cancer.

Discover more about our free post-publication promotion services ⬇️ https://www.genesandcancer.com/editorial-policies/ -publication-promotion

03/25/2026

Genes & Cancer Publication Ethics and Publication Malpractice Statements: https://www.genesandcancer.com/ethics-statement/

Genes & Cancer follows the guidelines based on the recommendations of the Committee on Publication Ethics (COPE). Genes & Cancercomplies with the Committee's Code of Conduct and adheres to its Best Practice Guidelines.

03/25/2026

: "Novel strategies to target chemoresistant triple-negative breast cancer"

DOI ⬇️
https://doi.org/10.18632/genesandcancer.204

https://doi.org/10.18632/genesandcancer.204 Jaganathan Venkatesh, Arun K. Rishi, Kaladhar B. Reddy

03/24/2026

✉️ How to Genes & Cancer:

https://www.genesandcancer.com/contact/

6666 East Quaker St., Suite 1 Orchard Park, NY 14127 Tel: 1-800-922-0957 (option 3) Fax: 1-716-313-2661 e-Fax: 1-716-608-1380

03/24/2026

: "Loss of TRP53 (p53) accelerates tumorigenesis and changes the tumor spectrum of SJL/J mice"

DOI ⬇️
https://doi.org/10.18632/genesandcancer.198

https://doi.org/10.18632/genesandcancer.198 Jane A. Branca, Benjamin E. Low, Ruth L. Saxl, Jennifer K. Sargent, Rosalinda A. Doty, Michael V. Wiles, Beth L. ...

03/23/2026

Visit the Genes & Cancer , containing papers since 2014: https://www.genesandcancer.com/archive/

The cover for Genes & Cancer Volume 16 (2025) features Figure 1 from "Analysis of pathogenic variants in retinoblastoma reveals a potential gain of function ...